Market revenue in 2023 | USD 915.7 million |
Market revenue in 2030 | USD 1,442.3 million |
Growth rate | 6.7% (CAGR from 2023 to 2030) |
Largest segment | Biomarker services |
Fastest growing segment | Genetic Services |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology/Histology, Specimen Management & Storage, Special Chemistry Services |
Key market players worldwide | LabConnect, Eurofins Scientific SE, A. P. Moller Maersk A/S ADR, ACM Global, Cerba Research, Synevo Central Labs, Versiti, Cenetron, Ampersand Capital Partners, Pacific Biomarkers, Cirion |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to central lab market will help companies and investors design strategic landscapes.
Biomarker services was the largest segment with a revenue share of 38.44% in 2023. Horizon Databook has segmented the Europe central lab market based on genetic services, biomarker services, microbiology services, anatomic pathology/histology, specimen management & storage, special chemistry services covering the revenue growth of each sub-segment from 2018 to 2030.
Europe accounts for a significant revenue share of central lab market due to the presence of developed economies, such as Germany, Spain, the UK, France, and Italy. These countries have an advanced laboratory infrastructure, which is anticipated to significantly boost clinical research prospects in the region.
Furthermore, growing trend of personalized medicine is projected to further accelerate the market growth. The increasing prevalence of genetic disorders and infectious diseases, coupled with growing investments in genomic research initiatives, is expected to drive the market.
However, uneven reimbursement policies may restrain the market growth. Europe became the focal point of the COVID-19 pandemic in early March 2020, with the virus spreading rapidly across the region.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe central lab market , including forecasts for subscribers. This continent databook contains high-level insights into Europe central lab market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account